Jade Biosciences, Inc. (JBIO) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $17.26M | -85.6% |
| 2024 | $119.60M | +565.8% |
| 2023 | $17.96M | +109.9% |
| 2022 | $8.56M | +190.6% |
| 2021 | $2.94M | +66.0% |
| 2020 | $1.77M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $17.26M | -85.6% |
| 2024 | $119.60M | +565.8% |
| 2023 | $17.96M | +109.9% |
| 2022 | $8.56M | +190.6% |
| 2021 | $2.94M | +66.0% |
| 2020 | $1.77M | — |